Cristina Ternero-Perez

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

C-Type Natriuretic Peptide Preserves Vascular and Cardiac Function in Sepsis.

C-Type Natriuretic Peptide Preserves Vascular and Cardiac Function in Sepsis.

Journal: Hypertension (Dallas, Tex. : 1979)
Published: February 04, 2026

Studying the Vascular Tone of Mouse Aortic Rings in a Standard Wire Myograph.

Studying the Vascular Tone of Mouse Aortic Rings in a Standard Wire Myograph.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 26, 2025

ATP-binding cassette B8 prevents endothelial dysfunction and atherosclerosis.

ATP-binding cassette B8 prevents endothelial dysfunction and atherosclerosis.

Journal: Redox biology
Published: July 14, 2025

Endothelium-derived C-type natriuretic peptide offsets the pathogenesis of pulmonary hypertension.

Endothelium-derived C-type natriuretic peptide offsets the pathogenesis of pulmonary hypertension.

Journal: Pharmacological research
Published: May 30, 2025

Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm.

Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: April 03, 2025

Cardiomyocyte-derived C-type natriuretic peptide diminishes myocardial ischaemic injury by promoting revascularisation and limiting fibrotic burden.

Cardiomyocyte-derived C-type natriuretic peptide diminishes myocardial ischaemic injury by promoting revascularisation and limiting fibrotic burden.

Journal: Pharmacological research
Published: September 16, 2024

Endogenous C-type natriuretic peptide offsets the pathogenesis of steatohepatitis, hepatic fibrosis, and portal hypertension.

Endogenous C-type natriuretic peptide offsets the pathogenesis of steatohepatitis, hepatic fibrosis, and portal hypertension.

Journal: PNAS nexus
Published: August 30, 2024

Novel enhancers of guanylyl cyclase-A activity acting via allosteric modulation.

Novel enhancers of guanylyl cyclase-A activity acting via allosteric modulation.

Journal: British journal of pharmacology
Published: August 26, 2022

C-type natriuretic peptide preserves central neurological function by maintaining blood-brain barrier integrity.

C-type natriuretic peptide preserves central neurological function by maintaining blood-brain barrier integrity.

Journal: Frontiers in molecular neuroscience
Published: July 11, 2022

A Series of Substituted Bis-Aminotriazines Are Activators of the Natriuretic Peptide Receptor C.

A Series of Substituted Bis-Aminotriazines Are Activators of the Natriuretic Peptide Receptor C.

Journal: Journal of medicinal chemistry
Published: March 25, 2022

C-type natriuretic peptide is a pivotal regulator of metabolic homeostasis.

C-type natriuretic peptide is a pivotal regulator of metabolic homeostasis.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 25, 2022

Hydropersulfides (RSSH) and Nitric Oxide (NO) Signaling: Possible Effects on S-Nitrosothiols (RS-NO).

Hydropersulfides (RSSH) and Nitric Oxide (NO) Signaling: Possible Effects on S-Nitrosothiols (RS-NO).

Journal: Antioxidants (Basel, Switzerland)
Published: December 16, 2021
Showing 1-12 of 13

Last Updated: 09/26/2026